Search for: "Bayer Laboratories, Inc." Results 81 - 100 of 161
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Aug 2010, 2:41 pm by Bexis
Ayerst Laboratories, Inc., 607 P.2d 1339, 1349-50 (Kan. [read post]
23 Jun 2010, 10:28 pm
(Patent Docs) Trilipix (Fenofibrate) - US: Patent infringement complaint following a Para IV certification: Abbott Laboratories et al. v. [read post]
26 May 2010, 4:09 am by Anthony Lake
Notable settlements in this area include Pfizer, Inc., which, at $2.3 billion, constitutes the largest healthcare fraud settlement in U.S. history, Eli Lilly Company; Abbott Laboratories, Inc.; and Bayer Healthcare, LLC. [read post]
20 May 2010, 9:55 pm by Patent Docs
Court of Appeals for the Second Circuit ruled that the "pay-for-delay" agreement between defendants Bayer AG and several generic drugmakers (including The Rugby Group, Watson Pharmaceuticals Inc., and Barr Laboratories Inc.) were not illegal under U.S. antitrust law and prevailing precedent. [read post]
19 May 2010, 6:15 am
(Patent Docs) US: CAFC affirms claim construction and corresponding summary judgment of non-infringement: Scantibodies Laboratory, Inc. v. [read post]
13 May 2010, 12:27 pm by Bexis
Bayer Pharmaceuticals Corp., 548 F. [read post]
28 Apr 2010, 9:59 pm by Patent Docs
(formerly Therasense, Inc.) and Abbott Laboratories; requested a response from Defendants-Appellees Becton, Dickinson & Co., Nova Biomedical Corp., and Bayer Healthcare LLC; granted Plaintiffs-Appellants leav to file a reply; and granted the Washington Legal Foundation, Nine Intellectual Property Law Professors, Hon. [read post]
27 Apr 2010, 10:58 pm
Solstice International Partners et al (Docket Report) US: FTC annual report highlights the Commission’s patent settlement efforts (FDA Law Blog)   Products Adcirca (Tadalafil) – US: Declaratory judgement of non-infringement and invalidity based on ANDA to manufacture generic Adcirca: Synthon v Eli Lilly et al (Patent Docs) Amrix (Cyclobenzaprine) – US: Mylan seeks declaratory judgment of noninfringement, unenforceability and invalidity of Amrix patent, based on Mylan’s… [read post]
4 Mar 2010, 12:38 am by Dr. Shezad Malik
Ocella, which is a generic version of Yasmin, is distributed by Barr Laboratories, Inc. [read post]
3 Mar 2010, 12:49 pm by Jason Krebs
  Bayer, makers of the popular, but problematic birth control drug Yaz and Yasmin wrote that there were, about 1,100 lawsuits pending in the United States served on Bayer on behalf of persons alleged to have suffered personal injuries, some of them fatal, from the use of Bayer’s oral contraceptive products Yasmin®, yaz® and / or Ocella, a generic version of Yasmin® distributed by Barr Laboratories, Inc. in the u.s. market. [read post]
3 Mar 2010, 7:55 am by Tom Lamb
" (Posted by Tom Lamb at DrugInjuryWatch.com) The Bayer Annual Report for 2009, at page 243, provides some updated information about the number of YAZ, Yasmin, and Ocella lawsuits that have been filed thus far: As of February 15, 2010, there were about 1,100 lawsuits pending in the United States served upon Bayer on behalf of persons alleged to have suffered personal injuries, some of them fatal, from the use of Bayer’s oral contraceptive products… [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]